Cytokinetics Stock Target Price and Analyst Consensus
| CYTK Stock | USD 50.25 1.15 2.34% |
The current analyst and expert consensus on Cytokinetics is Strong Buy with 8 buy recommendations. The current projected Cytokinetics target price consensus is 62.27, with 19 analyst opinions. Cytokinetics buy-or-sell recommendation module provides average expert sentiment on the projected Cytokinetics target price to derive its highest and lowest estimates based on target price estimated volatility of 2.5492. Check out Macroaxis Advice on Cytokinetics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For more information on how to buy Cytokinetics Stock please use our How to buy in Cytokinetics Stock guide.
Lowest Forecast 56.67 | Highest Forecast 69.12 | Target Price 62.27 |
Cytokinetics |
It's important to approach Cytokinetics' target price projections with caution. While they can be useful as part of a broader investment strategy, they are inherently speculative and subject to various kinds of risk, including market volatility and unforeseen external factors. Always consider multiple aspects and do your own research when making investment decisions.
Analysts determine stock price targets through various methods, including financial modeling, peer comparison, and company analysis. The stock price target is the analyst's best estimate of the future price of a stock and is used by investors to make investment decisions. However, it is important to note that stock price targets are not guaranteed, and the actual price of a stock can differ significantly from the target due to various factors such as market conditions, economic events, and company developments.
Steps to utilize Cytokinetics price targets
Cytokinetics' stock target price is an estimate of its future price, usually made by analysts. Using Cytokinetics' target price to determine if it is a suitable investment can be done through the following steps:- Look at Cytokinetics' target prices provided by various analysts and compare them. This can help you gain a more balanced view of the Stock's potential.
- Look at the analyst's track record to determine if they have a history of accurately predicting stock prices.
- Look at the Company's financials, including revenue, earnings, and debt, to determine if it is in good financial health.
- Consider market conditions. For example, take into account the state of the economy, competition, and regulatory environment, to determine if Cytokinetics' stock is likely to perform well.
- Diversify your portfolio and do not rely solely on stock target prices to make investment decisions. Invest in a mix of stocks, bonds, and other assets to manage risk.
Additional Cytokinetics Value Projection Modules
Most investment researchers agree that the mispricing and readjustment of any Stock value happens often and is sometimes even predictable, but there is no strong theory explaining why it happens. The current price of Cytokinetics is a key component of Cytokinetics valuation and have some predictive power on the future returns of a Cytokinetics.Sophisticated investors, who have witnessed many market ups and downs, anticipate that the market will even out over time. This tendency of Cytokinetics' price to converge to an average value over time is called mean reversion. However, historically, high market prices usually discourage investors that believe in mean reversion to invest, while low prices are viewed as an opportunity to buy.
Trending Themes
If you are a self-driven investor, you will appreciate our idea-generating investing themes. Our themes help you align your investments inspirations with your core values and are essential building blocks of your portfolios. A typical investing theme is an unweighted collection of up to 20 funds, stocks, ETFs, or cryptocurrencies that are programmatically selected from a pull of equities with common characteristics such as industry and growth potential, volatility, or market segment. | Casinos Invested over 90 shares | |
 | Macroaxis Index Invested few shares | |
 | Hedge Favorites Invested over 60 shares | |
 | Banking Invested over 20 shares | |
 | Baby Boomer Prospects Invested over 40 shares | |
 | Cash Cows Invested few shares | |
 | Driverless Cars Invested few shares | |
 | Momentum Invested over 50 shares | |
 | Macroaxis Picks Invested over 30 shares | |
 | Manufacturing Invested over 30 shares | |
 | FinTech Invested over 60 shares | |
 | ESG Investing Invested few shares |
Check out Macroaxis Advice on Cytokinetics to cross-verify analyst projections. Unlike analyst recommendations, Macroaxis provides advice only from the perspective of investor risk tolerance and investment horizon. For more information on how to buy Cytokinetics Stock please use our How to buy in Cytokinetics Stock guide.You can also try the Technical Analysis module to check basic technical indicators and analysis based on most latest market data.